Country

  • EN
  • FR

Quick access

  • Decrease character size
  • Standard character size.
  • Increase character size
  • Print

All countries

  • Brazil / Brasil
  • China / 中国
  • Germany / Deutschland
  • Japan / 日本
  • Korea / 한국
  • United Kingdom
  • United States

Company

  • Profile
  • Sustainability
  • Businesses
  • Worldwide presence

Investors

  • Share price
  • Financial results
  • Retail investors
  • Legal information

Media

  • News releases
  • Events
  • Publications
  • Contacts

Careers

  • Job opportunities
  • Career profiles
  • Student center
  • Internships

  • Forgot your password ?
  • Register

Homepage Rhodia

Worldwide presence
  • Our company
    • Profile
    • Strategy
    • Values
    • Corporate governance
    • Businesses
    • Worldwide presence
  • Markets & Products
    • Markets & solutions
    • Products
    • Leading brands
    • New products
    • Doing business with Rhodia
    • Suppliers
  • Sustainability
    • Vision
    • Rhodia Way
    • Our stakeholders
    • REACH
    • Responsible Care
    • Greenhouse Gases
    • News & Events
    • Reports & Indicators
    • Ratings & Awards
    • Publications
  • Innovation
    • At a glance
    • Business development
    • Breakthrough
    • Worldwide network
    • PG de Gennes prize
    • News & Events
  • News center
    • News releases
    • Download center
    • Events
    • Contacts
    • Rhodia at a glance
  • Investors
    • Rhodia in brief
    • Share information
    • Annual General Meeting
    • Financial results
    • News releases
    • Retail investors
    • Events / Calendar
    • Publications
    • Contacts
    • Legal information
  • Careers
    • Rhodia at a glance
    • HR philosophy
    • Career profiles
    • Job opportunities
    • Student center
  1. Home
  2. News center
  3. News releases
  • News releases
    • Download center
    • Events
    • Contacts
    • Rhodia at a glance

    Second quarter 2008 results logoNews release

    Paris – July 30, 2008

    Second quarter 2008 results:
    Rhodia demonstrates again its strong pricing power in a challenging environment
    Full year objectives confirmed

    Key highlights

    • Strong pricing power confirmed : +8.1%(1) price increases more than offsetting the sharp increase in raw materials and energy costs

    • Stability of volumes reflecting priority given to prices

    • Recurring EBITDA(1) stable at €187 million, despite significant transactional Forex impact

    • Substantial increase in Net Profit to €35 million

    • Full year objectives confirmed

    “Once again, Rhodia’s strong pricing power has allowed us to more than offset the unrelenting increases in raw material and energy costs," commented Rhodia Chairman and Chief Executive Officer Jean-Pierre Clamadieu. "On the back of satisfactory demand levels, we will continue to give priority to pricing. We remain therefore confident in the performance of our businesses despite the challenging feedstock environment and the strong Forex headwinds we are facing."

    Summary income statement

    In € million

    Q2 2007

    Q2 2007
    like for like(1)

    Q2 2008

    Variation
    like for like

    Net Sales

    1 222

    1 169

    1 227

    5%

    Recurring EBITDA(2)

    196

    185

    187

    1.1%

    Operating Profit

    115

    99

    115

    16%

    Profit from continuing operations

    7

    34

    Profit/(loss) from discontinued operations

    (3)

    2

    Net Profit/ Group Share

    3

    35

    Earnings per Share (in €)

    0.03

    0.35

    Free Cash Flow(3)

    83

    (15)

    (1) Like for like: at constant scope and currency conversion

    (2) Before restructuring and other operating income and expenses

    (3) Defined as “net cash provided by operating activities” plus “non recurring refinancing cash costs” minus Capital Expenditure

    1. Strong pricing fully offsets cost increases

    The 5% (1) increase in Net Sales was driven by a 8.1% positive impact from strong pricing in local currency. In a satisfactory demand environment, volumes were stable as Rhodia effectively gave priority to prices over volumes. The transactional foreign exchange impact was a negative (3.5)%.

    Recurring EBITDA(1) was stable. €95 million of price rises more than compensated for a €(78) million increase in raw material and energy costs. The transactional foreign exchange impact amounted to €(23) million. Fixed costs were under control and decreased by €7 million.

    Operating Profit(1) was up by 16% versus the second quarter of 2007 and amounted to €115 million.

    The Financial Result improved to €(56) million from €(84) million in the second quarter of 2007 which was impacted by a one-off financial restructuring charge of €(34) million. Net financial charges improved from €(38) to €(33) million.

    The Net Profit Group Share increased from €3 million in the second quarter of 2007 to €35 million in the second quarter of 2008.

    Earnings per Share rose to € 0.35 from €0.03 a year earlier.

    2. Free Cash Flow affected by temporarily negative Working Capital variance

    Due to the continuous disciplined management of investments, Capital Expenditure amounted to €65 million versus €76 million in the second quarter of 2007.

    Working Capital stood at 12.4% of Total Sales versus 12.9% a year earlier. However, Working Capital increased by €64 million versus the end of the first quarter of 2008, reflecting the impact of price increases and the temporary effect of the deployment of a new SAP based system in Rhodia’s USA operations.

    The temporary increase in Working Capital weighed on the Free Cash Flow which amounted to €(15) million.

    At €1,570 million on June 30, 2008, Consolidated Net Debt is nearly stable compared to €1,529 million on March 31, 2008.

    3. Overview by Enterprise

    Polyamide

    In € million

    Q2 2007

    Q2 2007

    Like for like

    Q2 2008

    Net Sales

    509

    497

    495

    Recurring EBITDA

    75

    74

    60

    The Polyamide Enterprise registered stable volumes, reflecting the Group’s policy to give priority to prices. New price initiatives were implemented in order to fully cover raw materials and energy cost increases. US competitors with available volumes due to the slowdown in the US market benefited from favorable currency and natural gas costs.

    The decline in the US Dollar against the Brazilian Real and the Euro led to a negative Forex impact of €(13) million.

    In the second half of the year, new price increases are underway to compensate for continuous raw material cost inflation, in particular for Butadiene.

    (1) Like for like: at constant scope and currency conversion


    Novecare

    In € million

    Q2 2007

    Q2 2007

    Like for like

    Q2 2008

    Net Sales

    247

    224

    240

    Recurring EBITDA

    33

    28

    30

    Novecare saw solid demand across all segments. Industrial Formulation volumes were flat, with growth in Asia and Latin America compensating for the slowdown in the US market. Strong price rises more than offset raw material and energy cost increases.

    The Enterprise was impacted by a €(5) million negative non cash Forex conversion effect.

    Market trends are expected to remain positive throughout 2008, allowing for further price increases.

    Silcea

    In € million

    Q2 2007

    Q2 2007

    Like for like

    Q2 2008

    Net Sales

    183

    178

    195

    Recurring EBITDA

    40

    39

    35

    As expected, Silcea saw a significant 30% improvement in recurring EBITDA versus the first quarter of 2008, reflecting new price increases, especially in Silica and Rare Earths. Fixed costs were up versus the second quarter of 2007 resulting from growth projects and the new diphenols facility in China.

    Silcea was impacted by a €(5) million negative Forex effect.

    The Enterprise sees an overall good level of demand continuing.

    Energy Services

    In € million

    Q2 2007

    Q2 2007

    Like for like

    Q2 2008

    Net Sales

    41

    41

    52

    Recurring EBITDA

    31

    31

    38

    €32 million of recurring EBITDA was generated from Carbon Emissions Reduction credits (CERs) versus €29 million in the second quarter of 2007. The cogeneration business is traditionally slow in the second quarter.

    For the full year 2008, Rhodia expects to produce 13 million tons of CERs. 92% of these credits have been secured at €15.2/ton.

    Acetow

    In € million

    Q2 2007

    Q2 2007

    Like for like

    Q2 2008

    Net Sales

    113

    110

    113

    Recurring EBITDA

    22

    22

    17

    Price rises more than offset the increases in raw material and energy costs. The business was impacted by a substantial negative € (7) million Forex impact.

    Current initiatives are expected to deliver a significant recurring EBITDA improvement starting in the third quarter of the year.


    Eco Services

    In € million

    Q2 2007

    Q2 2007

    Like for like

    Q2 2008

    Net Sales

    56

    49

    70

    Recurring EBITDA

    22

    18

    20

    Eco Services’ strong price rises more than offset rapidly increasing raw material (sulfur in particular) and energy costs. The non cash negative Forex conversion was €(4) million.

    In the coming months, Rhodia’s strong pricing power should continue allowing sulfur cost increases to be fully offset.

    4. Outlook

    In the second half of the year, demand levels should remain satisfactory with the third quarter expected to be traditionally lower reflecting the usual seasonality in continental Europe of Polyamide and Silcea, as well as CER sales phasing.

    The rise in raw material costs is expected to continue. Rhodia will pursue its policy to give priority to prices over volumes, to defend the profitability of all its businesses.

    Current conditions prevailing, the Group is confirming its 2008 full year objectives:

    Recurring EBITDA should be within 5% of the level achieved in 2007

    Earnings per Share should increase versus 2007

    In addition, solid generation of Free Cash Flow in the second half of 2008 and the disposal of the Isocyanates business will allow Rhodia to further reduce its Net Debt versus the end of 2007.

    This press release contains elements that are not historical facts including, without limitation, certain statements on future expectations and other forward-looking statements. Such statements are based on management’s current views and assumptions and involve known and unknown risks and uncertainties that could cause actual results, performance or events to differ materially from those anticipated.

    Rhodia is an international chemical company resolutely committed to sustainable development. As a leader in its businesses, the Group aims to improve its customers’ performance through the pursuit of operational excellence and its ability to innovate. Structured around six Enterprises, Rhodia is the partner of major players in the automotive, tire, electronics, perfume, health & beauty and home care markets. The Group employs around 15,000 people worldwide and generated sales of
    €4.8 billion in 2007. Rhodia is listed on Euronext Paris.

    Contacts

    Media Relations
    Rita Hillig +33 (0)1 53 56 64 04

    Investor Relations
    Loic Harrari +33 (0)1 53 56 64 80

    FINEO
    Anne Guimard/ François-José Bordonado +33 (0)1 53 56 64 59

    Results Fact Sheet : Q2-H1 2008

    Income Statement

    € million

    Q2*
    2007

    Q2*
    2008

    Variation

    H1**
    2007

    H1**
    2008

    Variation

    Net Sales

    1 222

    1 227

    0.4%

    2 408

    2 413

    0.2%

    Other revenue

    85

    107

    235

    258

    Recurring EBITDA

    196

    187

    (4.6)%

    392

    355

    (9.4)%

    Recurring EBITDA Margin(1)

    16.0%

    15.2%

    16.3%

    14.7%

    Depreciation & Amortization

    (66)

    (69)

    (137)

    (139)

    Other Gains and Losses

    (12)

    1

    7

    (2)

    Restructuring Costs

    (3)

    (4)

    (22)

    (6)

    Operating Profit

    115

    115

    -

    240

    208

    (13.3)%

    Financial Results

    (84)

    (56)

    (202)

    (98)

    Share of profit (loss) of associates

    -

    1

    -

    1

    Profit/(loss) before income tax

    31

    60

    93.5%

    38

    111

    192.1%

    Income tax

    (24)

    (26)

    (50)

    (37)

    Profit/(loss) from continuing operations

    7

    34

    (12)

    74

    Profit/(loss) from discontinued operations

    (3)

    2

    76

    4

    Net Profit/(loss)

    4

    36

    64

    78

    Net Profit/(loss) (Group Share)

    3

    35

    x10.7

    62

    77

    24.2%

    Earnings per share €

    0.03

    0.35

    0.62

    0.77

    Average number of shares outstanding

    100350875

    101087068

    100350069

    101027205

    (1) Recurring EBITDA margin excluding CERs 13.1% vs 14.1% in Q2 07 and 12.3% vs 14.2% in H1 07

    Net Sales

    Recurring EBITDA

    Operating Profit

    € million

    Q2*
    2007

    Q2*
    2008

    Variation

    Q2*
    2007

    Q2*
    2008

    Variation

    Q2*
    2007

    Q2*
    2008

    RHODIA

    1 222

    1 227

    0.4%

    196

    187

    (4.6)%

    115

    115

    POLYAMIDE

    509

    495

    (2.8)%

    75

    60

    (20.0)%

    26

    34

    NOVECARE

    247

    240

    (2.8)%

    33

    30

    (9.1)%

    23

    21

    SILCEA

    183

    195

    6.6%

    40

    35

    (12.5)%

    31

    25

    ENERGY SERVICES

    41

    52

    26.8%

    31

    38

    22.6%

    30

    36

    ACETOW

    113

    113

    -

    22

    17

    (22.7)%

    15

    10

    ECO SERVICES

    56

    70

    25.0%

    22

    20

    (9.1)%

    18

    17

    CORPORATE & Others

    73(1)

    62(1)

    (15.1)%

    (27)

    (13)

    51.9%

    (28)

    (28)

    Net Sales

    Recurring EBITDA

    Operating Profit

    € million

    H1**
    2007

    H1**
    2008

    Variation

    H1**
    2007

    H1**
    2008

    Variation

    H1**
    2007

    H1**
    2008

    RHODIA

    2 408

    2 413

    0.2%

    392

    355

    (9.4)%

    240

    208

    POLYAMIDE

    990

    971

    (1.9)%

    142

    112

    (21.1)%

    68

    63

    NOVECARE

    490

    475

    (3.1)%

    63

    58

    (7.9)%

    46

    40

    SILCEA

    368

    384

    4.3%

    76

    62

    (18.4)%

    57

    41

    ENERGY SERVICES

    84

    104

    23.8%

    83

    91

    9.6%

    77

    86

    ACETOW

    215

    226

    5.1%

    42

    37

    (11.9)%

    27

    23

    ECO SERVICES

    108

    127

    17.6%

    36

    33

    (8.3)%

    28

    26

    CORPORATE & Others

    153(1)

    126(1)

    (17.6)%

    (50)

    (38)

    24.0%

    (63)

    (71)

    (1) including intercompany sales elimination

    Net Financial Debt

    Dec. 31. 2007

    March 31. 2008

    June. 30. 2008

    1 484

    1529

    1 570

    2008 outlook

    ● Satisfactory level of demand

    ● Raw materials costs continuing to increase

    ● Price before volume strategy to continue

    ● Q3 traditionally lower than other quarters reflecting usual seasonality in
    continental Europe (Polyamide, Silcea) and CER sales phasing

    ● Recurring EBITDA confirmed within 5% of the level achieved in 2007 at current conditions

    ● EPS increase vs 2007 confirmed

    ● Solid generation of Free Cash Flow in H2 and disposal of Isocyanates
    business to drive further reduction of Net Debt vs the end of 2007

    * Unaudited
    ** Reviewed by auditors

    Results Fact Sheet : Q2 2008

    POLYAMIDE

    • Price-before-volume strategy: new price increases aimed at fully covering raw materials and energy cost increases. Price rises limited by US competitors with available volumes due to US slowdown, benefiting from favorable currency and natural gas costs

    • Stable volumes

    • €(13)m negative Forex due to decline in USD against BRL and Euro

    NOVECARE

    • Strong price rises more than offset raw materials & energy cost increases

    • Solid demand across all segments. Industrial Formulations flat, with growth in Asia and Latin America compensating for slowdown in the US

    • €(5)m negative non cash Forex conversion

    SILCEA

    • As expected, significant rise in EBITDA vs Q1 08 (+30%), reflecting new price increases, especially in Silica and Rare Earths

    • Increase in fixed costs vs Q2 07 resulting from growth projects and new diphenol facility in China

    • €(5)m negative Forex impact

    ENERGY SERVICES

    • €32m recurring EBITDA generated from CERs vs €29m Q2 07

    • Usual seasonality in cogeneration business

    ACETOW

    • Prices rises more than offset impact of raw materials and energy cost increases

    • Good level of demand

    • Substantial negative Forex impact €(7)m

    ECO SERVICES

    • Strong pricing more than offsets rapidly increasing raw materials (sulphur) and energy costs

    • €(4)m negative non cash Forex conversion

    € million

    Net Sales
    Q2* 2007

    Scope

    Foreign
    Exchange
    conversion

    Net Sales Q2* 2007
    like for like

    Foreign Exchange transaction

    Volume & mix

    Selling Price

    Net Sales
    Q2* 2008

    Variation Q2 2008-Q2 2007

    Variation Q2* 2008 – Q2* 2007 like for like

    RHODIA

    1 222

    3

    (56)

    1 169

    (41)

    4

    95

    1 227

    0.4%

    5.0%

    POLYAMIDE

    509

    (1)

    (11)

    497

    (25)

    5

    18

    495

    (2.8)%

    (0.4)%

    NOVECARE

    247

    0

    (23)

    224

    (2)

    (3)

    21

    240

    (2.8)%

    7.1%

    SILCEA

    183

    6

    (11)

    178

    (3)

    6

    14

    195

    6.6%

    9.6%

    ENERGY
    SERVICES

    41

    0

    0

    41

    0

    6

    5

    52

    26.8%

    26.8%

    ACETOW

    113

    0

    (3)

    110

    (9)

    4

    8

    113

    0.0%

    2.7%

    ECO
    SERVICES

    56

    0

    (7)

    49

    0

    (2)

    23

    70

    25.0%

    42.9%

    CORPORATE
    & Others

    including
    intercompany
    sales elimination

    73

    (2)

    (1)

    70

    (2)

    (12)

    6

    62

    (15.1)%

    (11.4)%

    € million

    Rec. EBITDA
    Q2*
    2007

    Scope

    Forex conversion

    Rec. EBITDA
    Q2* 2007
    like for like

    Volume & mix

    Selling
    Price

    Raw materials
    & Energy

    Forex transaction

    Fixed
    Costs

    Rec. EBITDA
    Q2* 2008

    Rec. EBITDA Margin
    Q2* 2008

    RHODIA

    196

    0

    (11)

    185

    1

    95

    (78)

    (23)

    7

    187

    15.2%

    POLYAMIDE

    75

    0

    (1)

    74

    (1)

    18

    (18)

    (12)

    (1)

    60

    12.1%

    NOVECARE

    33

    0

    (5)

    28

    (1)

    21

    (14)

    (2)

    (2)

    30

    12.5%

    SILCEA

    40

    2

    (3)

    39

    0

    14

    (14)

    (2)

    (2)

    35

    17.9%

    ENERGY
    SERVICES

    31

    0

    0

    31

    7

    5

    (2)

    0

    (3)

    38

    -

    ACETOW

    22

    1

    (1)

    22

    1

    8

    (7)

    (6)

    (1)

    17

    15.0%

    ECO
    SERVICES

    22

    0

    (4)

    18

    0

    23

    (21)

    0

    0

    20

    28.6%

    CORPORATE
    & Others

    (27)

    (3)

    3

    (27)

    (5)

    6

    (2)

    (1)

    16

    (13)

    -

    * Unaudited


    Results Fact Sheet : H1 2008

    € million

    Net
    Sales

    H1**
    2007

    Scope

    Foreign
    Exchange
    conversion

    Net
    Sales
    H1**
    2007
    like
    for
    like

    Foreign
    Exchange
    transaction

    Volume
    & mix

    Selling Price

    Net
    Sales
    H1**
    2008

    Variation
    H1** 2008
    -H1** 2007

    Variation
    H1** 2008
    – H1** 2007
    like for like

    RHODIA

    2 408

    (1)

    (95)

    2 312

    (80)

    31

    150

    2 413

    0.2%

    4.4%

    POLYAMIDE

    990

    (3)

    (13)

    974

    (54)

    21

    30

    971

    (1.9)%

    (0.3)%

    NOVECARE

    490

    (1)

    (42)

    447

    (1)

    (3)

    32

    475

    (3.1)%

    6.3%

    SILCEA

    368

    10

    (19)

    359

    (6)

    9

    22

    384

    4.3%

    7.0%

    ENERGY
    SERVICES

    84

    0

    0

    84

    0

    11

    9

    104

    23.8%

    23.8%

    ACETOW

    215

    0

    (5)

    210

    (17)

    18

    15

    226

    5.1%

    7.6%

    ECO
    SERVICES

    108

    0

    (14)

    94

    0

    (1)

    34

    127

    17.6%

    35.1%

    CORPORATE
    & Others
    including
    intercompany
    sales elimination

    153

    (7)

    (2)

    144

    (2)

    (24)

    8

    126

    (17.6)%

    (12.5)%

    € million

    Rec. EBITDA
    H1**
    2007

    Scope

    Forex
    conversion

    Rec. EBITDA
    H1**
    2007

    like
    for
    like

    Volume
    & mix

    Selling
    Price

    Raw materials
    & Energy

    Forex transaction

    Fixed
    Costs

    Rec. EBITDA
    H1**
    2008

    Rec.
    EBITDA
    Margin

    H1**
    2008

    RHODIA

    392

    (1)

    (17)

    374

    9

    150

    (135)

    (42)

    (1)

    355

    14.7%

    POLYAMIDE

    142

    (1)

    (1)

    140

    3

    30

    (34)

    (25)

    (2)

    112

    11.5%

    NOVECARE

    63

    1

    (9)

    55

    2

    32

    (25)

    (1)

    (5)

    58

    12.2%

    SILCEA

    76

    2

    (4)

    74

    (3)

    22

    (24)

    (5)

    (2)

    62

    16.1%

    ENERGY
    SERVICES

    83

    1

    0

    84

    10

    9

    (4)

    0

    (8)

    91

    -

    ACETOW

    42

    1

    (1)

    42

    5

    15

    (14)

    (10)

    (1)

    37

    16.4%

    ECO
    SERVICES

    36

    0

    (6)

    30

    1

    34

    (29)

    0

    (3)

    33

    26.0%

    CORPORATE
    & Others

    (50)

    (5)

    4

    (51)

    (9)

    8

    (5)

    (1)

    20

    (38)

    -

    ** Reviewed by auditors

    Results Fact Sheet : Quarterly results

    €m

    Q1* 2007

    Q1* 2008

    Q2* 2007

    Q2* 2008

    H1** 2007

    H1** 2008

    Q3* 2007

    Q4* 2007

    H2* 2007

    FY* 2007

    RHODIA

    Net Sales

    1 186

    1 186

    1 222

    1 227

    2 408

    2 413

    1 187

    1 186

    2 373

    4 781

    Recurring EBITDA

    196

    168

    196

    187

    392

    355

    179

    187

    366

    758

    Rec. EBITDA margin

    16.5%

    14.2%

    16.0%

    15.2%

    16.3%

    14.7%

    15.1%

    15.8%

    15.4%

    15.9%

    Operating Profit

    125

    93

    115

    115

    240

    208

    105

    77

    182

    422

    POLYAMIDE

    Net Sales

    481

    476

    509

    495

    990

    971

    494

    491

    985

    1 975

    Recurring EBITDA

    67

    52

    75

    60

    142

    112

    68

    70

    138

    280

    Rec. EBITDA margin

    13.9%

    10.9%

    14.7%

    12.1%

    14.3%

    11.5%

    13.8%

    14.3%

    14.0%

    14.2%

    Operating Profit

    42

    29

    26

    34

    68

    63

    43

    45

    88

    156

    NOVECARE

    Net Sales

    243

    235

    247

    240

    490

    475

    227

    214

    441

    931

    Recurring EBITDA

    30

    28

    33

    30

    63

    58

    25

    21

    46

    109

    Rec. EBITDA margin

    12.3%

    11.9%

    13.4%

    12.5%

    12.9%

    12.2%

    11.0%

    9.8%

    10.4%

    11.7%

    Operating Profit

    23

    19

    23

    21

    46

    40

    14

    11

    25

    71

    SILCEA

    Net Sales

    185

    189

    183

    195

    368

    384

    179

    189

    368

    736

    Recurring EBITDA

    36

    27

    40

    35

    76

    62

    33

    29

    62

    138

    Rec. EBITDA margin

    19.5%

    14.3%

    21.9%

    17.9%

    20.7%

    16.1%

    18.4%

    15.3%

    16.8%

    18.8%

    Operating Profit

    26

    16

    31

    25

    57

    41

    20

    16

    36

    93

    ENERGY SERVICES

    Net Sales

    43

    52

    41

    52

    84

    104

    60

    58

    118

    202

    Recurring EBITDA

    52

    53

    31

    38

    83

    91

    41

    57

    98

    181

    Operating Profit

    47

    50

    30

    36

    77

    86

    40

    48

    88

    165

    ACETOW

    Net Sales

    102

    113

    113

    113

    215

    226

    112

    114

    226

    441

    Recurring EBITDA

    20

    20

    22

    17

    42

    37

    20

    21

    41

    83

    Rec. EBITDA margin

    19.6%

    17.7%

    19.5%

    15.0%

    19.5%

    16.4%